Work

SAT0126 Evaluation of two dosing regimens of certolizumab pegol for maintenance of clinical response in patients with active rheumatoid arthritis: Primary results from doseflex, a phase IIIB study

Year: 2012

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2012-eular.3073

Authors: D.E. Furst, S.A. Shaikh, M. Greenwald, B. Bennett, F. Staelens, W. Koetse, P. Bertin

Institutions: University of California, Los Angeles, McMaster University, UCB Pharma (Belgium), UCB Pharma (United States), Centre Hospitalier Universitaire de Limoges, Hôpital Universitaire Dupuytren

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2318611526

Cites:

Cited by: 6

Related to: 10